Copyright
©2007 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 28, 2007; 13(40): 5317-5323
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5317
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5317
Antioxidant therapy for chronic hepatitis C after failure of interferon: Results of phase II randomized, double-blind placebo controlled clinical trial
Ezra Gabbay, Ehud Zigmond, Nila Hemed, Mina Rowe, Yaron Ilan, Orit Pappo, Liver Unit, Department of Medicine; Department of Pathology, Hebrew University, Hadassah Medical Center, Jerusalem IL-91120, Israel
George Zabrecky, Robert Cohen, Marcus Foundation, Atlanta, United States
Author contributions: All authors contributed equally to the work.
Supported by The Bernie Markus Foundation
Correspondence to: Yaron Ilan, MD, Liver Unit, Department of Medicine, Hebrew University, Hadassah Medical Center, POB 12000, Jerusalem IL-91120, Israel. deborah@hadassah.org.il
Telephone: +972-2-6778231 Fax: +972-2-6431021
Received: December 14, 2006
Revised: August 17, 2007
Accepted: September 14, 2007
Published online: October 28, 2007
Revised: August 17, 2007
Accepted: September 14, 2007
Published online: October 28, 2007
Core Tip